Home
About
Overview
Sharing Data
ORCID
Help
History (41)
Cytochrome P450 Family 21
Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.
Atrial Fibrillation in Heart?Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
Health-Related Quality of Life in Heart?Failure With Preserved Ejection?Fraction: The PARAGON-HF Trial.
See All 41 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Health-Related Quality of Life in Heart?Failure With Preserved Ejection?Fraction: The PARAGON-HF Trial.
Health-Related Quality of Life in Heart?Failure With Preserved Ejection?Fraction: The PARAGON-HF Trial. JACC Heart Fail. 2019 10; 7(10):862-874.
View in:
PubMed
subject areas
Age Factors
Aged
Aged, 80 and over
Aminobutyrates
Angiotensin Receptor Antagonists
Biphenyl Compounds
Comorbidity
Diuretics
Drug Combinations
Female
Heart Failure
Humans
Male
Middle Aged
Natriuretic Peptide, Brain
Peptide Fragments
Quality of Life
Randomized Controlled Trials as Topic
Self Efficacy
Severity of Illness Index
Sex Factors
Stroke Volume
Tetrazoles
Valsartan
authors with profiles
Michael R. Zile